Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Telso_Sopharma_EN_2023.09.04WarrantSell.pdf Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 4 September 2023.

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 105 / 2023
Date of issue: 2023-09-05
Short name of the issuer
SOPHARMA AD
Subject
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 4 September 2023.
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 4 September 2023.
Annexes
File Description
Telso_Sopharma_EN_2023.09.04WarrantSell.pdf
Telso_Sopharma_EN_2023.09.04WarrantSell.pdf		 Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 4 September 2023.

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2023-09-05 Ognian Donev Executive Director
20230905_112458_0942570167_Telso_Sopharma_EN_2023.09.04WarrantSell.pdf

Pobierz